Cancer is the second highest cause of death globally, with about 70% of deaths occurring in
low-or middle-income countries, thus calling for efficient cures. Nanotechnology research …

For over a century, modern therapy has been at battle with malignancy, with no apparent
victory in sight. Cancer therapies have come a long way, but they still need to be more …

Camptothecin (CPT), an alkaloid isolated from the Camptotheca tree, has demonstrated
significant anticancer properties in a range of malignancies. However, its therapeutic …

The escalating prevalence of cancer, a condition in which uncontrolled cell growth leads to
complications and tissue failure, is one of the major concerns of healthcare professionals …

Type II diabetes mellitus is one of major lifestyle disorders worldwide. Despite numerous
therapeutic interventions, cases and adverse health effects are still rising. Many plant …

On a global scale, lung cancer is acknowledged to be the major driver of cancer death
attributable to treatment challenges and poor prognosis. Classical cancer treatment …

Nanoparticles are increasingly employed to treat various cancers. The therapeutic efficiency
of any drug delivery system depends on the capacity of this system to internalize into the …

To achieve a fine balance between the onset of therapeutic efficacy and the incidence of
side effects, various drug delivery systems have been intelligently fabricated to achieve …

Lung cancer, the second leading cause of cancer-related mortality and incidence globally,
presents a formidable challenge with an estimated 238,340 new cases and 127,070 deaths …

Remarkable technological advances have been recently made to treat cancer, such as site-
specific delivery of drugs. Both passive and active targeting are expected to targeting only …